申请人:Phytera, Inc.
公开号:US06307070B1
公开(公告)日:2001-10-23
A method for treating a fungal infection is disclosed. The method includes administering to a patient a pharmaceutical composition containing a compound of formula (IA):
where each R is independently H, OH, Br, Cl, I, amino, thiol, nitro, C1-4 alkoxy, C1-4 alkenyloxy, C2-6 alkoxyalkyleneoxy, C1-4 alkylthio, C3-18 alkyl, or C3-18 alkenyl; or two adjacent R's, taken together, are a C2-18 bivalent moiety containing at least one oxgen atom, substituted or disubstituted with A or B or both, A being H, OH, Br, Cl, I, amino, or thiol, and B being H, C1-10 alkyl, C2-18 alkenyl, or C6-18 aryl; provided at least two Rs are not H;
X is C4-10 alkyl, C4-20 alkenyl, or a C4-20 single, C6-20 bridged, or C6-20 fused ring moiety containing cycloalkyl, cycloalkenyl, aryl, heterocycle, or heteroaryl, where X is substituted with H, OH, Cl, Br, I, amino, cyano, nitro, alkyl, alkoxy, alkenyl, or alkenyloxy; provided that if X is a heteroaryl or heterocyclic moiety where two Rs are each OH and meta to each other, then the remaining R is H and ortho to each of the two hydroxyls, and Y and Z are each O and a ring atom of X is linked directly to the sp2 carbon atom adjacent to X, then substituted with H, OH, Cl, Br, I, amino, cyano, alkyl, alkoxy, alkenyl, or alkenyloxy; and each of Y and Z is independently selected from O, S, and NH; or a pharmaceutically acceptable salt or ester thereof.
本发明涉及一种治疗真菌感染的方法,该方法包括向患者施用含有化合物(IA)的药物组合物,其中每个R都是独立的H、OH、Br、Cl、I、氨基、硫醇、硝基、C1-4烷氧基、C1-4烯氧基、C2-6烷氧基烷氧基、C1-4烷基硫基、C3-18烷基或C3-18烯基;或两个相邻的R在一起是一个含有至少一个氧原子的C2-18二价基团,用A或B或两者替代或二者替代,其中A为H、OH、Br、Cl、I、氨基或硫醇,B为H、C1-10烷基、C2-18烯基或C6-18芳基;前提是至少有两个R不是H;X为C4-10烷基、C4-20烯基或含有环烷基、环烯基、芳基、杂环或杂芳基的C4-20单一、C6-20桥式或C6-20融合环基团,其中X被H、OH、Cl、Br、I、氨基、氰基、硝基、烷基、烷氧基、烯基或烯氧基替代;前提是如果X是一个杂芳基或杂环基团,其中两个R分别为OH并且相对于彼此的meta位,那么其余的R为H并且正交于这两个羟基的每一个,而且Y和Z分别为O,并且X的一个环原子直接连接到X相邻的sp2碳原子,然后用H、OH、Cl、Br、I、氨基、氰基、烷基、烷氧基、烯基或烯氧基替代;并且Y和Z中的每一个都是独立选择的O、S和NH;或其药学上可接受的盐或酯。